1. Statement before the Subcommittee on Science, Research and Technology, US House of Representatives;Kennedy, D.,1979
2. The drug lag revisited: comparison by therapeutic area of patterns of drugs marketed in the United States and Great Britain from 1972 through 1976;Wardell, W.M.;Clin Pharmacol Ther,1978
3. Towards a more rational regulation of the development of new medicines. Report of a European workshop;Dengle, H.J.;Eur Y Clin Pharmacol,1977
4. Clinically significant adverse effects in a phase I testing program;Zarafonetis, C.J.D.; Riley, P.A.; Willis, P.W.;Clin Pharmacol Ther,1978
5. Statement before the Subcommittee on Science, Research and Technology, US House of Representatives;Wardell, W.M.,1979